Weight Loss
New Weight Loss Pill Foundayo Approved in the UK
Orforglipron is Eli Lilly's new once-daily GLP-1 pill, now approved in both the US and the UK as Foundayo. Here's what the trial data shows and what UK approval means for patients.
Foundayo
MHRA-approved GLP-1 treatment for weight loss, shown to help people lose around 11% of their body weight on average over more than a year, with greater flexibility thanks to no food, water or timing restrictions.
Coming soon
Be the first to try Foundayo
Register your interest and we will let you know when Foundayo is available.
Be the first to know when it's available
No commitment — just register your interest
We'll only email you with genuine availability updates
Why GLP-1's are a game changer for weight loss
Reducing hunger
GLP-1 medications work by signalling to your brain that you're full, helping to naturally reduce your appetite and food intake.
Slowing gastric emptying
These medications slow down how quickly food leaves your stomach, helping you feel satisfied for longer after eating.
Reducing cravings
GLP-1 treatments help reduce cravings, especially for high-calorie foods, making it easier to stick to healthier eating habits.
How it works
1
Online health consultation:
Complete a secure online consultation covering your medical history and elgibility for treatment.
2
Personal video consultation:
If you're new to Totiva, you'll have a personal video consultation with a clinician to discuss your health, goals, and treatment options.
3
Clinical review & prescribing:
Following your consultation, your clinician carefully reviews everything discussed. If treatment is appropriate, a prescription is issued.
4
Ongoing clinical support:
You'll have continued access to clinical support for follow-ups, treatment reviews, and questions as your care continues.
What our patients say
Trusted by patients across the UK
Want to hear when Foundayo is available?
Join the waitlist and we will let you know when there is an update about Foundayo.
